Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Onkure Therapeutics Inc increased its cash reserves by 38.67%, or 7.71m. Cash Flow from Financing totalled 60.87m or -- of revenues. In addition the company used 63.68m for operations while cash from investing totalled 10.52m.
Cash flow per share | -12.24 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 22.14 |
---|---|
Tangible book value per share | 22.14 |
More ▼
Balance sheet in USDView more
Current ratio | 23.71 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼